Stock Events

Elevance Health 

$541.91
664
-$2.49-0.46% Friday 20:00

Statistics

Day High
550.96
Day Low
541.72
52W High
567.26
52W Low
431.38
Volume
691,992
Avg. Volume
966,179
Mkt Cap
129.14B
P/E Ratio
19.49
Dividend Yield
1.2%
Dividend
6.52

Upcoming

Dividends

1.2%Dividend Yield
10Y Growth
14.06%
5Y Growth
15.3%
3Y Growth
12.99%
1Y Growth
10.14%

Earnings

16OctExpected
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Next
5.62
7.29
8.97
10.64
Expected EPS
9.702346
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ELV. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Unitedhealth
UNH
Mkt Cap545B
UnitedHealth Group offers health insurance services similar to Elevance Health, making it a direct competitor in the healthcare insurance sector.
Cigna)
CI
Mkt Cap101.14B
Cigna operates in the same health insurance industry, offering a range of health services and insurance products that compete with Elevance Health.
ANTHEM INC COM STK (IN)
ANTM
Mkt Cap89.63B
Anthem, now known as Elevance Health, competes with itself through its various subsidiaries and divisions in the health insurance market.
Humana
HUM
Mkt Cap42.68B
Humana is a health insurance company that provides similar insurance products and health plans, competing directly with Elevance Health.
CVS Health
CVS
Mkt Cap72.01B
CVS Health, through its Aetna division, offers health insurance services that compete with Elevance Health's offerings.
Molina Healthcare
MOH
Mkt Cap20.5B
Molina Healthcare provides managed health care services under Medicaid and Medicare, competing in the same government-sponsored segment as Elevance Health.
Centene
CNC
Mkt Cap41.47B
Centene Corporation operates in the health insurance industry, focusing on under-insured and uninsured individuals, competing with Elevance Health's insurance products.
Gilead Sciences
GILD
Mkt Cap98.35B
Gilead Sciences, a biopharmaceutical company, indirectly competes with Elevance Health by affecting healthcare costs and insurance coverage through its drug pricing.
Johnson & Johnson
JNJ
Mkt Cap399.26B
Johnson & Johnson, a broad healthcare company, indirectly competes with Elevance Health through its extensive range of healthcare products and services that impact health insurance coverage and costs.

Analyst Ratings

604.29$Average Price Target
The highest estimate is $649.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy
93%
Hold
7%
Sell
0%

About

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Show more...
CEO
Gail Boudreaux
Employees
104900
Country
US
ISIN
US0367521038

Listings